Niccoli, Giampaolo <br/><br/>
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.  [electronic resource] 

 -  European heart journal  Aug 2008 
 - 1843-50 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1522-9645 
<br/><br/><label>Standard No.: </label>10.1093/eurheartj/ehn325  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Biomarkers--blood<br/>Coronary Angiography<br/>Coronary Circulation--drug effects<br/>Electrocardiography<br/>Endothelin-1--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--blood<br/>No-Reflow Phenomenon--blood<br/>Risk Assessment<br/>Thromboxane A2--blood<br/>Treatment Outcome